Browsing Tag
Humacyte
5 posts
Humacyte (HUMA) posts positive Phase 3 dialysis access data, then raises $50m at a discount on the strength of it
Humacyte (HUMA) posts positive Phase 3 dialysis access data and raises $50M at a discount. FDA filing planned for H2 2026. Read the full executive analysis.
Humacyte’s $60mn funding boost sparks mixed investor reaction over equity dilution
Humacyte raises $60 million in an oversubscribed direct offering as investors debate dilution risks and long-term biotech value. Read the analysis.
FDA extends review period for Humacyte’s vascular trauma treatment ATEV
The U.S. Food and Drug Administration’s review of Humacyte, Inc.’s innovative vascular trauma treatment, known as the acellular…
Humacyte to merge with Alpha Healthcare Acquisition Corp in $1.1bn deal to advance regenerative medicine
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare…
Humacyte begins phase 2 Humacyl vascular trauma trial
Humacyl vascular trauma trial : Humacyte, a regenerative medical technology company, has started a phase 2 clinical trial…